JPRN-UMIN000031063招募中未知
Risk prediction of progression to multiple myeloma from MGUS or smoldering myeloma by multi-color flow cytometric analysis - MM-MFC2017
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are not set up. However, patients who received anti-myeloma treatment are excluded.
研究者
相似试验
进行中（未招募）
不适用
Cohort Construction and Prognostic Model Construction for Multiple MyelomaMultiple MyelomaNCT06366802The First Affiliated Hospital of Soochow University1,000
尚未招募
早期 1 期
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple MyelomaMultiple MyelomaNCT06379451Changzhou No.2 People's Hospital9
终止
1 期
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaRelapsed and/or Refractory Multiple MyelomaNCT06351644Adriana Rossi2
Enrolling By Invitation
不适用
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)Multiple MyelomaNCT03689595Dana-Farber Cancer Institute30,000
进行中（未招募）
1 期
Tackling early deaths and assessing quality of life in patients with myeloma: assessing the effect of preventative antibiotics on healthcare associated infectionsInfections during early symptomatic multiple myelomaMedDRA version: 18.1 Level: LLT Classification code 10028566 Term: Myeloma System Organ Class: 100000004864EUCTR2011-000366-35-GBniversity of Birmingham1,000